/
Other
9.8KDiseases↗
10.1KPipeline Programs↗
22.2KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
105,018
clinical trials
Completed60,835 · 58%
Unknown status11,615 · 11%
Recruiting11,434 · 11%
Terminated6,515 · 6%
Not yet recruiting6,262 · 6%
Active, not recruiting3,607 · 3%
Other4,750 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
TED
Most programs42
Programs
8,311
Trials
22
Recruiting
Pre
13
P1
3
P2
21
P3
5
Appr
3
Most programs:
Roche
RocheAIN
Most trials32
Programs
5,850
Trials
15
Recruiting
Pre
11
P1
3
P2
15
P3
3
Appr
—
Most programs:AAvyxa
MPA
Highest activity45
Programs
5,424
Trials
17
Recruiting
Pre
26
P1
14
P2
3
P3
2
Appr
4
Most programs:
Daewoong Pharmaceutical Co. LTD.
Daewoong Pharmaceutical Co. LTD.Tics
2109 programs2707 trialsApproved
UTI
0 programs2674 trials
ILD
16 programs2500 trialsApproved
CLE
14 programs2117 trialsPhase 3
TIA
15 programs1926 trialsPhase 3
POI
0 programs1056 trials
SLE
2 programs1025 trialsApproved
NAS
0 programs959 trials
Prostate CA
0 programs941 trials
NSCLC
2159 programs733 trialsApproved
SCLC
28 programs854 trialsPhase 2
Cognitive
31 program825 trialsPreclinical
GIST
6 programs708 trialsApproved
OSA
7 programs690 trialsPhase 2
Eating
20 programs686 trials
STEMI
25 programs673 trialsApproved
Ovarian
20 programs610 trialsPhase 3
ACL
0 programs596 trials
Sleep
1013 programs564 trialsApproved
PROC
3 programs526 trialsPhase 2
Knee
12 programs523 trialsPhase 2
Fibrosis
164 programs336 trialsApproved
Implant
20 programs497 trials
Chinese
0 programs489 trials
Coma
0 programs485 trials
Biomarkers
5 programs470 trialsApproved
Screening
7 programs465 trialsPhase 2
Showing top 30 diseases by activity. 9758 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)